Kenji Tsuchihashi

Scopus著者プロファイル

ウェブサイトhttps://hyoka.ofc.kyushu-u.ac.jp/html/100023078_ja.html

h-index

年別の研究成果

フィンガープリント

Kenji Tsuchihashiが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。

1 類似のプロファイル

95 学術誌
1 コメント/討論

Age-related real-world treatment patterns and outcomes of localised, high-grade osteosarcoma
Fujiwara, T., Iwata, S., Nagano, A., Tsuchihashi, K., Kawai, A. & Ozaki, T., 6月 2026, In: Journal of Bone Oncology. 58, 100767.
研究成果: ジャーナルへの寄稿 › 学術誌 › 査読

Open Access
Clinical outcomes and genomic alterations in patients with metastatic malignant phyllodes tumors
Takigawa, A., Tsuchihashi, K., Nio, K., Ide, K., Kusano, W., Doi, Y., Ohmura, H., Kuwayama, M., Yamaguchi, K., Ito, M., Oshima, K., Tamura, S., Isobe, T., Arita, S., Ariyama, H., Kusaba, H., Akashi, K. & Baba, E., 2月 1 2026, In: Japanese journal of clinical oncology. 56, 2, p. 139-147 9 p.
研究成果: ジャーナルへの寄稿 › 学術誌 › 査読
Comparison of first-line cetuximab and panitumumab plus doublet chemotherapies for left-sided colorectal cancer: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum
Kawagoe, R., Moriwaki, T., Yamazaki, K., Yukami, H., Uetake, H., Tsuda, M., Suto, T., Sugimoto, N., Ojima, H., Takii, Y., Yasui, H., Komoda, M., Shimada, Y., Tsuji, A., Yamaguchi, T., Sawada, R., Shinozaki, K., Otsu, S., Shigeyasu, K. & Tsuchihashi, K. & 6 others, Tamura, T., Shiozawa, M., Ueno, H., Denda, T., Ito, T. & Takashima, A., 5月 2026, In: International Journal of Clinical Oncology. 31, 5, p. 851-858 8 p.
研究成果: ジャーナルへの寄稿 › 学術誌 › 査読
Drug Repurposing Screen Identifies Pimozide as a ROS-Inducing Therapy With Anti-Tumor Efficacy in HNSCC PDX Models
Okazaki, S., Nakamura, S., Soma, T., Yoshikawa, M., Asoda, S., Nakajima, Y., Tsuchihashi, K., Ohmura, M., Goitsuka, R., Imai, K., Saya, H., Nagano, O. & Ozawa, H., 2月 2026, In: Cancer Science. 117, 2, p. 511-521 11 p.
研究成果: ジャーナルへの寄稿 › 学術誌 › 査読

Open Access
ENVELOPE: enfortumab vedotin in patients with advanced small bowel adenocarcinoma refractory or intolerant to platinum-based therapy—phase II investigator-initiated trial (NCCH2412/MK015)
Fujii, H., Hirano, H., Kudo, T., Tsuchihashi, K., Shoji, H., Okita, N., Hirose, T., Takashima, A., Yokoyama, M., Kawasaki, M., Shuda, Y., Naito, M., Ichikawa, K., Sekine, K., Sato, J., Yamamoto, N. & Kato, K., 6月 2026, In: ESMO Gastrointestinal Oncology. 12, 100322.
研究成果: ジャーナルへの寄稿 › 学術誌 › 査読

Open Access

土橋賢司

フィンガープリント

過去5年の共同研究と上位研究分野

詳細を開く

Age-related real-world treatment patterns and outcomes of localised, high-grade osteosarcoma

Clinical outcomes and genomic alterations in patients with metastatic malignant phyllodes tumors

Comparison of first-line cetuximab and panitumumab plus doublet chemotherapies for left-sided colorectal cancer: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum

Drug Repurposing Screen Identifies Pimozide as a ROS-Inducing Therapy With Anti-Tumor Efficacy in HNSCC PDX Models

ENVELOPE: enfortumab vedotin in patients with advanced small bowel adenocarcinoma refractory or intolerant to platinum-based therapy—phase II investigator-initiated trial (NCCH2412/MK015)

土橋 賢司

フィンガープリント

過去5年の共同研究と上位研究分野

研究成果

Age-related real-world treatment patterns and outcomes of localised, high-grade osteosarcoma

Clinical outcomes and genomic alterations in patients with metastatic malignant phyllodes tumors

Comparison of first-line cetuximab and panitumumab plus doublet chemotherapies for left-sided colorectal cancer: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum

Drug Repurposing Screen Identifies Pimozide as a ROS-Inducing Therapy With Anti-Tumor Efficacy in HNSCC PDX Models

ENVELOPE: enfortumab vedotin in patients with advanced small bowel adenocarcinoma refractory or intolerant to platinum-based therapy—phase II investigator-initiated trial (NCCH2412/MK015)

土橋賢司